Clemens C Cyran

Summary

Country: Germany

Publications

  1. pmc Regorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation
    Clemens C Cyran
    Department of Clinical Radiology, Laboratory for Experimental Radiology, University Hospitals Munich, Grosshadern Campus, Muenchen, Germany
    PLoS ONE 8:e76009. 2013
  2. doi request reprint Visualization, imaging and new preclinical diagnostics in radiation oncology
    Clemens C Cyran
    Department of Clinical Radiology, Laboratory of Experimental Radiology, University of Munich Hospitals, Campus Großhadern, Marchioninistrase 15, 81377 Munich, Germany
    Radiat Oncol 9:3. 2014
  3. pmc Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model
    Clemens C Cyran
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California San Francisco, San Francisco, California Department of Clinical Radiology, Laboratory for Experimental Radiology, University Hospitals Munich, Campus Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany Electronic address
    Acad Radiol 20:1256-63. 2013
  4. pmc Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF)
    Clemens C Cyran
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California San Francisco, Box 0628, 505 Parnassus Ave, San Francisco, CA 94143 0628, United States
    Eur J Radiol 81:891-6. 2012
  5. doi request reprint Perfusion MRI for monitoring the effect of sorafenib on experimental prostate carcinoma: a validation study
    Clemens C Cyran
    Department of Clinical Radiology, Center for Experimental Radiology, University Hospitals Munich, Campus Grosshadern, Ludwig Maximilians University Munich, Marchioninistrasse 15, 81377 Munich, Germany
    AJR Am J Roentgenol 198:384-91. 2012
  6. doi request reprint Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas
    Clemens C Cyran
    Department of Clinical Radiology, Center for Experimental Radiology, University Hospitals Munich Campus Grosshadern, Ludwig Maximilians University Munich, Munich, Germany
    Invest Radiol 47:49-57. 2012
  7. doi request reprint Quantification of supra-aortic arterial wall inflammation in patients with arteritis using high resolution dynamic contrast-enhanced magnetic resonance imaging: initial results in correlation to [18F]-FDG PET/CT
    Clemens C Cyran
    Department of Clinical Radiology, University Hospitals Munich Campus Grosshadern, Ludwig Maximilians University Munich, Germany
    Invest Radiol 46:594-9. 2011
  8. doi request reprint Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature
    Clemens C Cyran
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    Invest Radiol 43:298-305. 2008
  9. doi request reprint Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers
    Clemens C Cyran
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    Eur Radiol 19:121-31. 2009
  10. doi request reprint New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues
    Clemens C Cyran
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    J Magn Reson Imaging 27:581-9. 2008

Detail Information

Publications15

  1. pmc Regorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation
    Clemens C Cyran
    Department of Clinical Radiology, Laboratory for Experimental Radiology, University Hospitals Munich, Grosshadern Campus, Muenchen, Germany
    PLoS ONE 8:e76009. 2013
    ....
  2. doi request reprint Visualization, imaging and new preclinical diagnostics in radiation oncology
    Clemens C Cyran
    Department of Clinical Radiology, Laboratory of Experimental Radiology, University of Munich Hospitals, Campus Großhadern, Marchioninistrase 15, 81377 Munich, Germany
    Radiat Oncol 9:3. 2014
    ....
  3. pmc Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model
    Clemens C Cyran
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California San Francisco, San Francisco, California Department of Clinical Radiology, Laboratory for Experimental Radiology, University Hospitals Munich, Campus Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany Electronic address
    Acad Radiol 20:1256-63. 2013
    ....
  4. pmc Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF)
    Clemens C Cyran
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California San Francisco, Box 0628, 505 Parnassus Ave, San Francisco, CA 94143 0628, United States
    Eur J Radiol 81:891-6. 2012
    ..To correlate dynamic MRI assays of macromolecular endothelial permeability with microscopic area-density measurements of vascular endothelial growth factor (VEGF) in tumors...
  5. doi request reprint Perfusion MRI for monitoring the effect of sorafenib on experimental prostate carcinoma: a validation study
    Clemens C Cyran
    Department of Clinical Radiology, Center for Experimental Radiology, University Hospitals Munich, Campus Grosshadern, Ludwig Maximilians University Munich, Marchioninistrasse 15, 81377 Munich, Germany
    AJR Am J Roentgenol 198:384-91. 2012
    ....
  6. doi request reprint Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas
    Clemens C Cyran
    Department of Clinical Radiology, Center for Experimental Radiology, University Hospitals Munich Campus Grosshadern, Ludwig Maximilians University Munich, Munich, Germany
    Invest Radiol 47:49-57. 2012
    ....
  7. doi request reprint Quantification of supra-aortic arterial wall inflammation in patients with arteritis using high resolution dynamic contrast-enhanced magnetic resonance imaging: initial results in correlation to [18F]-FDG PET/CT
    Clemens C Cyran
    Department of Clinical Radiology, University Hospitals Munich Campus Grosshadern, Ludwig Maximilians University Munich, Germany
    Invest Radiol 46:594-9. 2011
    ....
  8. doi request reprint Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature
    Clemens C Cyran
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    Invest Radiol 43:298-305. 2008
    ....
  9. doi request reprint Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers
    Clemens C Cyran
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    Eur Radiol 19:121-31. 2009
    ..The significant correlation between MRI and fluorescence microscopic measures of MMCM extravasation supports the utility of the non-invasive MRI approach for assessing the action of thalidomide on tumor blood vessels...
  10. doi request reprint New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues
    Clemens C Cyran
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    J Magn Reson Imaging 27:581-9. 2008
    ....
  11. pmc In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media
    Clemens C Cyran
    Department of Clinical Radiology, Laboratory for Experimental Radiology, University of Munich Hospitals Campus Grosshadern, Ludwig Maximilians University Munich, Marchioninistrasse 15, 81377 Munich, Germany C C Cyran and B Schwarz contributed equally to this research project, and share first authorship
    Cancer Imaging 13:557-66. 2013
    ....
  12. pmc Age determination of vessel wall hematoma in spontaneous cervical artery dissection: a multi-sequence 3T cardiovascular magnetic resonance study
    Maximilian Habs
    Dept, of Clinical Radiology, University of Munich, Grosshadern Campus, Munich, Germany
    J Cardiovasc Magn Reson 13:76. 2011
    ..Using these classifications, we systematically investigated the value of cardiovascular magnetic resonance (CMR) in determining the age of vessel wall hematoma (VWH) in patients with spontaneous cervical artery dissection (sCAD)...
  13. pmc Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by in vivo high-resolution CMR--a comparative analysis
    Jochen M Grimm
    Institute for Clinical Radiology, Ludwig Maximilians University Hospital Munich, Pettenkoferstrasse 8a, Munich, Germany
    J Cardiovasc Magn Reson 14:80. 2012
    ..The purpose of this study was to evaluate the influence of chronic lipid apheresis (LA) on the composition of atherosclerotic carotid plaques...
  14. pmc High resolution carotid black-blood 3T MR with parallel imaging and dedicated 4-channel surface coils
    Tobias Saam
    Department of Clinical Radiology, University of Munich, Grosshadern Campus, Munich, Germany
    J Cardiovasc Magn Reson 11:41. 2009
    ..The purpose of this study was to evaluate a multi-sequence, black-blood MR protocol using parallel imaging and a dedicated 4-channel surface coil for vessel wall imaging of the carotid arteries at 3 T...
  15. doi request reprint 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease
    Axel Rominger
    Department of Nuclear Medicine, University of Munich, Munich, Germany
    J Nucl Med 50:1611-20. 2009
    ..Our objective was to evaluate the association of arterial (18)F-FDG uptake and calcifications in large arteries as detected by (18)F-FDG PET/CT with the subsequent occurrence of vascular events in otherwise asymptomatic cancer patients...